M.D.

Cardiff Oncology Inc (NASDAQ: CRDF) shares are trading lower after the company announced data from its lead clinical program evaluating onvansertib in combination with standard-of-care FOLFIRI/bevacizumab. "As we have increased the number of patients evaluated and the duration of follow-up,...

Nuvation Bio Inc (NYSE: NUVB) shares are trading higher after the company announced FDA clearance of its investigational new drug application for NUV-422. "FDA clearance of our third IND application for NUV-422 is another important achievement for our lead investigational CDK 2/4/6 inhibitor...